Related Experiment Video
Updated: Jul 12, 2026
08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
[Emergence extensive drug resistance tuberculosis (XDR)]
H Vier1, T Schaberg, A Gillissen
1Robert-Koch-Klinik, Thoraxzentrum des Klinikums St. Georg, Leipzig.
Pneumologie (Stuttgart, Germany)
|August 31, 2007
Summary
Multi-drug resistant tuberculosis (MDR-Tb) and extensively drug-resistant tuberculosis (XDR-Tb) pose significant global health threats. Effective national TB control programs and new drug development are crucial to combat these resistant strains.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Context:
- Multi-drug resistant tuberculosis (MDR-Tb) and extensively drug-resistant tuberculosis (XDR-Tb) are critical global health challenges.
- These resistant strains of Mycobacterium tuberculosis are increasingly prevalent worldwide.
- Current treatment options are limited due to bacterial persistence and rapid resistance development.
Purpose:
- To inform about the current threat of emerging XDR-Tb.
- To summarize potential strategies for controlling XDR-Tb.
- To highlight the urgent need for novel anti-tuberculosis drugs.
Summary:
- MDR-Tb is defined by resistance to isoniazid and rifampicin, while XDR-Tb includes resistance to fluoroquinolones and injectables.
- Preventing XDR-Tb relies on robust national TB control programs and susceptibility-guided treatment.
- Mycobacterium tuberculosis's ability to form dormant bacteria and develop resistance complicates treatment.
Impact:
- Emphasizes the critical need for enhanced global TB control efforts.
- Underscores the importance of developing new therapeutic agents against resistant tuberculosis.
- Informs public health strategies to mitigate the spread and impact of XDR-Tb.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...